CTI BioPharma Corp. logo
CTI BioPharma Corp. CTIC
$ 9.09 0.0%

Квартальный отчет 2023-Q1
добавлен 15.05.2023

report update icon

CTI BioPharma Corp. Мультипликаторы 2011-2024 | CTIC

Мультипликаторы по годам CTI BioPharma Corp.

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-5.9 -1.7 -4.5 -1.8 -2.2 -2.7 -2.5 -2.0 -3.5 -8.9 -0.8 -3.0

P/S

10.2 - 56235.3 21.0 2.5 4.4 2.3 14.7 5.4 10.9 - -

EPS

-0.8 -1.1 -0.7 -0.7 -0.5 -1.2 -1.9 -0.7 -0.7 -0.4 -2.0 -0.7

EV (Enterprise Value)

664 млн 174 млн 214 млн 67.4 млн 66.1 млн 122 млн 142 млн 206 млн 310 млн 358 млн 75.2 млн 174 млн

EBITDA per Share

-0.68 -1.05 -0.664 -0.679 -0.564 -1.06 -1.73 -6.14 -5.73 -3.49 -16.9 -20.6

EV/EBITDA

-1.0 -4.3 -1.2 -1.4 -2.5 -2.2 -1.4 -3.2 -8.1 -0.4 -2.0

PEG

4.94 0.95 0.62 0.05 -0.04 -0.08 -0.03 0.94 0.07 -0.11 -0.02 -0.06

P/B

-31.3 45.5 5.9 3.9 1.2 6.8 16.7 5.0 8.5 8.9 2.6 6.7

P/CF

-6.8 -2.0 -5.6 -2.5 -1.6 -2.8 -1.7 -2.5 -8.2 -10.1 -1.3 -3.0

ROE %

529.06 -2599.10 -131.03 -223.20 -55.38 -252.77 -670.48 -251.88 -242.65 -99.96 -307.72 -222.64

ROA %

-73.85 -135.17 -90.06 -86.47 -32.64 -74.10 -81.46 -82.74 -101.17 -45.61 -137.53 -100.19

ROCE %

453.99 -2530.71 -115.94 -143.63 -48.28 -110.92 -211.93 -162.21 -154.13 -56.17 -196.99 -164.64

Current Ratio

0.9 1.1 3.2 1.9 3.6 2.4 1.4 1.9 2.2 4.0 2.7 2.9

DSO

52.1 - - - 189.9 18.6 51.9 6.4 12.2 2.5 - -

DIO

38.1 - - - - 551.5 404.2 535.3 1705.5 13518.3 - -

DPO

306.4 - - - 1867.8 2595.1 1915.7 1991.3 2592.1 13457.0 - -

Операционный цикл

90.1 - - - 189.9 570.1 456.1 541.7 1717.7 13520.8 - -

Финансовый цикл

-216.2 - - - -1677.9 -2025.0 -1459.6 -1449.7 -874.4 63.8 - -

Все данные представлены в валюте USD

Мультипликаторы поквартально CTI BioPharma Corp.

2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.1 - -0.13 -0.21 -0.37 - -0.26 -0.21 -0.23 - -0.15 -0.19 -0.2 - -0.17 -0.19 -0.19 - -0.26 -0.2 -0.08 -0.33 -0.28 0.03 -0.71 -0.23 -1.04 -0.71 0.12 -0.13 -0.19 -0.19 -0.16 -0.27 0.03 -0.19 -0.2 0.08 -0.2 -0.17 -0.18 -0.2 -0.38 -1.38 -0.43 -0.47 -0.8 -0.14 -0.35

EBITDA per Share

-0.07 - -0.09 -0.17 -0.35 - -0.24 -0.21 -0.22 - -0.14 -0.13 -0.19 - -0.16 -0.18 -0.18 - -0.25 -0.24 -0.08 - -0.26 0.18 -0.68 - -1 -0.67 0.16 - -0.18 -0.17 -0.16 - 0.06 -0.18 -0.19 - -0.13 -158 -0.17 -0.17 -0.25 -1.14 -0.43 -0.24 -0.37 -0.1 -0.1

ROE %

669.05 655.98 593.80 438.35 -23.07 -158.84 -182.90 -144.78 -147.87 -89.47 -131.89 -150.25 -161.59 -134.38 -159.61 -142.43 -115.43 -51.40 -116.80 -146.46 -102.40 -186.45 -168.89 -333.10 -506.25 -390.49 -391.92 -235.45 -149.69 -229.52 -279.80 -206.14 -209.11 -223.61 -101.48 -146.91 -121.17 -94.62 -171.03 -180.58 -285.81 -293.40 -270.79 -284.85 -198.93 -217.15 -58.02 -59.19 -68.72

ROA %

-54.23 -57.84 -81.73 -92.89 -101.44 -89.63 -108.96 -104.42 -103.07 -64.30 -86.01 -88.38 -88.05 -68.78 -85.27 -80.04 -68.96 -33.58 -59.57 -64.90 -42.45 -74.10 -58.09 -81.98 -122.78 -81.46 -89.26 -66.15 -57.80 -82.82 -110.08 -82.49 -89.58 -101.17 -45.25 -66.82 -56.35 -45.61 -81.72 -85.74 -134.54 -137.53 -126.70 -132.86 -92.16 -100.19 -26.77 -27.31 -31.71

ROCE %

539.59 556.34 496.21 363.52 -26.13 -155.78 -179.37 -142.84 -136.20 -78.37 -119.37 -136.78 -158.21 -131.87 -157.03 -141.20 -118.64 -56.41 -110.35 -139.13 -91.11 -118.35 -333.56 -494.83 -662.15 -327.38 -388.79 -234.99 -151.47 -173.86 -155.97 -76.66 -80.90 -112.22 -146.50 -198.68 -174.33 -114.80 -169.36 -178.92 -282.37 -293.75 -273.71 -283.11 -199.05 -216.56 -53.24 -58.92 -69.89

Current Ratio

0.8 0.9 0.9 1.0 0.8 1.1 1.6 4.9 2.6 3.2 3.2 3.2 3.2 1.6 1.6 1.6 1.6 2.4 2.4 2.4 2.4 1.4 1.4 1.4 1.4 1.1 1.1 1.1 1.1 1.5 1.5 1.5 1.5 1.8 1.8 1.8 1.8 2.5 2.5 2.5 2.5 2.7 2.7 2.7 2.7 3.0 3.0 3.0 3.0

DSO

72.5 - 46.9 39.2 48.2 - - - - - - - - - - - - - - - 0.0 18.2 17.7 1.0 23.1 3.8 7.8 4.7 0.8 2.3 26.7 23.4 38.4 10.3 4.6 136.6 72.6 0.7 59.2 70.1 9.5 - - - - - - - -

DIO

56.3 - 73.2 40.0 16.7 - - - - - - - - - - - - - - 43.8 - - 761.1 643.4 - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

150.3 - 219.4 274.8 1036.6 - - - - - - - - - - - - - 3600.4 698.0 - - 3422.5 3027.6 - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

128.8 - 120.1 79.2 65.0 - - - - - - - - - - - - - - 43.8 0.0 18.2 778.7 644.4 23.1 3.8 7.8 4.7 0.8 2.3 26.7 23.4 38.4 10.3 4.6 136.6 72.6 0.7 59.2 70.1 9.5 - - - - - - - -

Финансовый цикл

-21.5 - -99.3 -195.6 -971.6 - - - - - - - - - - - - - -3600.4 -654.3 0.0 18.2 -2643.8 -2383.2 23.1 3.8 7.8 4.7 0.8 2.3 26.7 23.4 38.4 10.3 4.6 136.6 72.6 0.7 59.2 70.1 9.5 - - - - - - - -

Все данные представлены в валюте USD